BioArray News GenomeWeb News Premium Content Existing subscribers login here. New to BioArray News? For a trial subscription click here.

Industry, Academics or All of the Above:
Who Will the MAQC Results Benefit Most?

[September 12, 2006]

By Justin Petrone

While the results are scarcely a week old, it appears that array manufacturers and larger testing services and core labs may be the first to benefit from the results of the MAQC project. In particular, industry and larger labs will be able to use the standard assays and data provided by the results to aid in proficiency testing, customer support, and product development.

Login | Subscribe